Hemant Surgical

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0GYI01028
  • NSEID:
  • BSEID: 543916
INR
382.10
-3.4 (-0.88%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 10000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003854,
    "name": "Hemant Surgical",
    "stock_name": "Hemant Surgical",
    "full_name": "Hemant Surgical Industries Ltd",
    "name_url": "stocks-analysis/hemant-surgical",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "382.10",
    "chg": -3.4,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "385.50",
    "mcapval": "490.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543916,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE0GYI01028",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "02:32 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": 10000,
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hemant-surgical-1003854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 157,
    "sid": "1003854",
    "stock_news_url": "https://www.marketsmojo.com/news/hemant-surgical-industries-1003854"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
      "datetime": "01-Jun-2026",
      "details": "With reference to intimation dated May 27 2026 the Company has completed the acqusition of Lifesenz Cancer Labs Private Limited and has become subsidiary of the Company w.e.f. June 01 2026.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Non-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "27-May-2026",
      "details": "The Company at its meeting held today i.e. May 27 2026 has entered into Share Purchase Agreement (SPA) for acquisition of 66.66% equity shareholding of Lifesenz Cancer Labs Private Limited Mumbai.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Updates on Acquisition

01-Jun-2026 | Source : BSE

With reference to intimation dated May 27 2026 the Company has completed the acqusition of Lifesenz Cancer Labs Private Limited and has become subsidiary of the Company w.e.f. June 01 2026.

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Non-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31 2026

Announcement under Regulation 30 (LODR)-Acquisition

27-May-2026 | Source : BSE

The Company at its meeting held today i.e. May 27 2026 has entered into Share Purchase Agreement (SPA) for acquisition of 66.66% equity shareholding of Lifesenz Cancer Labs Private Limited Mumbai.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available